000 | 01755 a2200529 4500 | ||
---|---|---|---|
005 | 20250516072558.0 | ||
264 | 0 | _c20120427 | |
008 | 201204s 0 0 eng d | ||
022 | _a1464-3405 | ||
024 | 7 |
_a10.1016/j.bmcl.2011.12.057 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYang, Michael G | |
245 | 0 | 0 |
_aSynthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2). _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cFeb 2012 |
||
300 |
_a1384-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAmides _xchemical synthesis |
650 | 0 | 4 |
_aAminobenzoates _xchemical synthesis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCyclization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMicrosomes _xenzymology |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aProtein Binding _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReceptors, CCR2 _xantagonists & inhibitors |
650 | 0 | 4 | _aStereoisomerism |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aSubstrate Specificity |
650 | 0 | 4 |
_aSulfur _xchemistry |
700 | 1 | _aXiao, Zili | |
700 | 1 | _aShi, Qing | |
700 | 1 | _aCherney, Robert J | |
700 | 1 | _aTebben, Andrew J | |
700 | 1 | _aDe Lucca, George V | |
700 | 1 | _aSantella, Joseph B | |
700 | 1 | _aMo, Ruowei | |
700 | 1 | _aCvijic, Mary Ellen | |
700 | 1 | _aZhao, Qihong | |
700 | 1 | _aBarrish, Joel C | |
700 | 1 | _aCarter, Percy H | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 22 _gno. 3 _gp. 1384-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2011.12.057 _zAvailable from publisher's website |
999 |
_c21442917 _d21442917 |